8,956
Total Claims
$1.2M
Drug Cost
829
Beneficiaries
$1,389
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-9%
Cost per patient vs peers
$1,389 vs $1,524 avg
+4%
Brand preference vs peers
14.1% vs 13.7% avg
Brand vs Generic
86% generic
Brand: 1,266 claims · $993K
Generic: 7,690 claims · $158K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 767 | $671K |
| Sacubitril/Valsartan | 133 | $137K |
| Evolocumab | 80 | $73K |
| Rivaroxaban | 33 | $28K |
| Evolocumab | 29 | $24K |
| Alirocumab | 28 | $23K |
| Potassium Chloride | 555 | $20K |
| Atorvastatin Calcium | 1,184 | $16K |
| Isosorbide Dinitrate | 257 | $15K |
| Ranolazine | 99 | $13K |
| Ticagrelor | 20 | $11K |
| Ezetimibe | 265 | $9,841 |
| Rosuvastatin Calcium | 548 | $8,454 |
| Carvedilol | 875 | $7,551 |
| Diltiazem Hcl | 189 | $7,426 |
Prescribing Profile
47
Unique Drugs
$836K
Patient Profile
75
Avg Age
57%
Female
1.57
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About